Topic summary

Reaching a dose and staying there for a year: a longitudinal note — does this still hold?

Practice › Dosing & titration missed dose tirzepatide dose reduction titration semaglutide Solved

This is a generated summary. It shows the 6 most-liked posts from a topic of 40, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

s.silvaTL2 Moderator15 Jun 2025#2

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

24 likes 13mo

mi.almeidaTL2 Moderator Solution2 Jul 2025#7

post #6 is right about the mechanism and I think understates the practical bit.

Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that very small increments are hard to measure accurately with a syringe.

7 likes 13mo

a.petrovTL2 Moderator7 Jul 2025#9

n.torrence, post #8: Worth separating two things that post #4 runs together. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long half-life, four weeks approaches steady state and you can assess the dose fairly. That is an argument for not going… Go to post

Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you stay at an intermediate dose for years is not formally studied and extrapolation is the best available reasoning.

23 likes in reply to #8 13mo

e.coelhoTL2 Moderator31 Jul 2025#19

When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a reasonable response. If the side effect is not dose-dependent (e.g., hypoglycemia with insulin), dose reduction does not address the issue.

24 likes 12mo

n.abernathyTL3Analytical chemist13 Aug 2025#25

post #24 answers the question as asked. The question underneath it is different.

27 likes 11mo

glossary_checkTL2Member25 Aug 2025#31

s.cardoso, post #17: I read post #15 twice before replying, because I had assumed the opposite. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by real-world reports. The dose does not seem to stop working, but the longest trials are not… Go to post

Coming back to post #29, because the follow-up matters more than the original answer.

The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long half-life, four weeks approaches steady state and you can assess the dose fairly. That is an argument for not going faster. It is not an argument against going slower.

25 likes in reply to #17 11mo

Read the full topic (40 posts)

This topic was referenced in

Escalating every six weeks instead of four: what I observed over eight months — one year onPractice › Dosing & titration · 59 replies
How the published trials escalated, tabulated side by side — does this still hold?Practice › Dosing & titration · 2 replies
Restarting after a long gap: what the labelling implies — the long versionPractice › Dosing & titration · 17 replies

Suggested topics

Topic	Participants	Replies	Views	Activity
The arithmetic of an intermediate dose between two label steps Practice › Dosing & titration dose reduction semaglutide missed dose On the subject in the title: The arithmetic of an intermediate dose between two label steps Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am…		2	136	2mo
The lowest dose that does anything: is that a real question? Practice › Dosing & titration dose reduction worked example missed dose titration Asking directly, because I could not find a straight answer: The lowest dose that does anything: is that a real question? I have read the maintained page on this and I still have a gap, so I am asking rather…	+100	111	9.1k	5mo
About the Dosing & titration category Practice › Dosing & titration titration dose reduction worked example Pinned Wiki Schedules, escalation intervals, dose reductions, and the arithmetic that connects a vial to a syringe mark. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…		4	350	4mo
How the published trials escalated, tabulated side by side — does this still hold? Practice › Dosing & titration dose reduction tirzepatide missed dose Solved Asking directly, because I could not find a straight answer: How the published trials escalated, tabulated side by side — does this still hold? A question about technique rather than about dose. I have been…		2	8.9k	9mo
Reaching a dose and staying there for a year: a longitudinal note Practice › Dosing & titration worked example tirzepatide titration semaglutide Reaching a dose and staying there for a year: a longitudinal note Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have a…		2	763	15mo

Related topics — sharing the tags missed dose, tirzepatide, dose reduction

Topic	Participants	Replies	Views	Activity
Escalating every six weeks instead of four: what I observed over eight months — one year on Practice › Dosing & titration missed dose semaglutide dose reduction titration On the subject in the title: Escalating every six weeks instead of four: what I observed over eight months — one year on Working notes rather than a conclusion. I have read the maintained page on this and I…	+55	59	9.1k	10mo
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still hold? Practice › Administration injection site rotation missed dose aseptic technique subcutaneous injection Wiki Asking directly, because I could not find a straight answer: Air bubbles in a subcutaneous injection: the honest risk assessment — does this still hold? Reporting something rather than asking about it, in…	+21	30	20k	4mo
Why a pen's dose steps are fixed and what that costs you Devices › Pens & autoinjectors dead volume storage subcutaneous injection missed dose Solved The question in the title: Why a pen's dose steps are fixed and what that costs you I will give what I have already checked below so nobody repeats it. I have read the maintained page on this and I still have…		4	2.5k	23h
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Compounds › Tirzepatide tirzepatide SURPASS programme randomised trial effect size Solved Closed Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with STEP 2 ( Lancet ,…	+150	163	22k	11mo
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Compounds › Semaglutide SELECT trial type 2 diabetes semaglutide Semaglutide half-life: where the 165 to 184 hour figure comes from Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in…	+112	119	3.3k	11mo